Fairfield, Bush & Co. Zimmer Biomet Holdings, Inc. Transaction History

Fairfield, Bush & Co.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$102.72 - $121.7 $67,281 - $79,713	655 New	655 $79.7 Million
Q1 2023 May 15, 2023	BUY	$121.91 - $130.94 $574,805 - $617,382	4,715 New	4,715 $609 Million
Q2 2022 Aug 09, 2022	SELL	$102.23 - $133.85 $15,947 - $20,880	-156 Reduced 17.91%	715 $75,000
Q1 2022 May 06, 2022	BUY	$108.42 - $129.58 $94,433 - $112,864	871 New	871 $111,000
Q4 2021 Feb 09, 2022	SELL	$115.43 - $146.63 $461,720 - $586,520	-4,000 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$136.35 - $158.76 $851,096 - $990,979	-6,242 Reduced 60.95%	4,000 $585,000
Q2 2021 Aug 02, 2021	BUY	$152.95 - $173.41 $763,373 - $865,489	4,991 Added 95.05%	10,242 $1.64 Million
Q3 2020 Nov 18, 2020	BUY	$113.59 - $141.68 $22,718 - $28,336	200 Added 3.96%	5,251 $694,000
Q4 2019 Feb 12, 2020	SELL	$127.4 - $146.83 $637 - $734	-5 Reduced 0.1%	5,051 $734,000
Q4 2017 Feb 22, 2018	BUY	$105.55 - $120.83 $16,465 - $18,849	156 Added 3.18%	5,056 $610,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,900	4,900 $629,000

1,081

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.2B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.